Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2
Cellular ImmunologyPublished 1 October 1989
Kam H. Leung
Citations35
SJR quartileQ2
SJR score1.26
SNIP0.73
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Activation of natural killer activity K562 target cells from nonadherent (NA) lymphocytes by interleukin 2 (IL-2) was inhibited marginally PGE2 (30-3000 nM) and the LAK activity was more sensitive than the NK activity to P GE2-mediated suppression.
Abstract
Activation of natural killer (NK) activity K562 target cells from nonadherent (NA) lymphocytes by interleukin 2 (IL-2) was inhibited marginally PGE2 (30-3000 nM). PGE2 did not effectively suppress the NK activity of IL-2-activated cells. The NK activation and acquisition of resistance to PGE2-mediated suppression of NK activity were dependent on protein synthesis. When NA cells were incubated with IL-2 for 3 or more days to generate lymphokine-activated killer (LAK) activity against Raji target cells, PGE2 only partially inhibited the activation of NK/LAK activity by an optimal dose of IL-2 (10 U/ml). The activation of NK/LAK activity by a suboptimal dose of IL-2 (0.1 U/ml) was inhibited by PGE2. When the NK/LAK activity of IL-2-activated cells was assessed in the presence or absence of PGE2, the LAK activity was more sensitive than the NK activity to PGE2-mediated suppression.
Keywords
Immunology and Microbiology
ScienceLeukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
2,853 Citations1983Bengt Samuelsson
Leukotrienes C4, D4, and E4, which are released from the lung tissue of asthmatic subjects exposed to specific allergens, seem to play a pathophysiological role in immediate hypersensitivity reactions.
The Journal of Experimental MedicineLymphokine-activated killer cells. Analysis of progenitors and effectors.
398 Citations1986John R. Ortaldo, Anna Mason +1 more
Accumulated data suggest that there is not a single unique progenitor of LAK activity, but rather that multiple subsets of lymphocytes become cytotoxic in response to IL-2.
PubMedSuccessful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.
380 Citations1985René Lafrenière, Steven A. Rosenberg
Treatment with RIL-2 alone or in combination with LAK cells is effective in reducing the number of established hepatic micrometastases in a murine model.
Immunology TodayImmunotherapy of cancer using interleukin 2: current status and future prospects
257 Citations1988Steven A. Rosenberg
Steven Rosenberg details his group's work on LAK cell therapy, and suggests how the clinical benefits gained so far can be improved upon.
Life SciencesProstaglandins and the immune response
174 Citations1977Louis M. Pelus, Helen R. Strausser
No definitive evidence exists that compounds other than the classical Pgs are active in immune cell inhibition, but the recent indications that Pgs may mediate their effects through the cyclic endoperoxides and non-prostanoate metabolites may prove to be an important challenge to the many proposed roles of Pgs.
The Journal of Immunology<i>In vivo</i> role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats.
167 Citations1983Teresa Barlozzari, Craig W. Reynolds +1 more
Results provide direct support for the hypothesis that NK cells are involved in in vivo resistance to tumors, particularly in the elimination of potentially metastatic tumor cells from the circulation and capillary beds.
NatureProstaglandin modulation of development of cell-mediated immunity in culture
159 Citations1980Kam H. Leung, Enrico Mihich
The data summarized here implicate PGs, thromboxane A2 (TXA2) and prostacyclin (PGI2) in the regulation of cellular immune responses at the inductive phase.
The Journal of ImmunologyThe effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
122 Citations1988Arnon Nagler, Lewis L. Lanier +1 more
It is shown that rIL-4 is a potent regulator of IL-2-dependent mechanisms of NK cell activation and proliferation and thus may play an important physiologic role in vivo.
PubMedEnhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic.
79 Citations1989Roderich E. Schwarz, Nikola L. Vujanović +1 more
The results indicate that the administration of unfractionated LAK cells plus interleukin 2 (IL-2) was effective in reducing established lung or liver metastases in this rat model, and suggest that purified populations of A-LAK cells (derived from natural killer cells) may prove superior for adoptive immunotherapy in the clinical setting.
PubMedAntitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.
74 Citations1986James J. Mulé, Stephen E. Ettinghausen +3 more
The studies described in this paper showed that the combination of i.v.-transferred lymphokine-activated killer (LAK) cells and i.p. injections of recombinant interleukin-2 (RIL-2) was highly effective in vivo in reducing established pulmonary metastases of natural killer cell-resistant, MCA-105 sarcoma and B16 melanoma in mice.
Cancer Immunology ImmunotherapyProstaglandin E and cancer Growth
58 Citations1980J. Goodwin, Gunnar Husby +1 more
The evidence linking prostaglandin E (PGE) with the growth of neoplastic tissue is reviewed and it is not yet clear whether the antitumor properties of these PG synthetase inhibitors are due to their releasing the hostimmune system from the chronic prostag landin-mediated suppression of the tumor, resulting in an effective immune response to the tumor.
The Journal of ImmunologyRegulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2.
49 Citations1982K H Leung, Hillel S. Koren
The data suggest that IFN-stimulated NK cells are protected from suppression by PGE2, and theIFN-induced protective effect may be beneficial to host resistance to neoplasia.
The Journal of ImmunologyPotentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase.
48 Citations1988Suzanne K. Beckner, William L. Farrar
The data indicate that the stimulation of lymphokine-activated killer cell differentiation and lymphocyte proliferation in human cells share a common initial biochemical signal, and modulation of this enzyme complex, positively or negatively, can regulate the ultimate physiologic response to IL-2.
Cellular ImmunologyThe regulatory effect of adherent cells on lymphokine activated killer cells
42 Citations1987Yukihiro Ibayashi, Dave S.�B. Hoon +1 more
It is found that adherent cells clearly down-regulate LAK cell induction, and PGE2 inhibits the induction of LAK effector cells by inhibiting the expression of the transferrin receptor on LAK cells.
The Journal of ImmunologyErythromyeloid tumor cells (K562) induce PGE synthesis in human peripheral blood monocytes.
30 Citations1983K H Leung, Dina G. Fischer +1 more
The production of PGE by monocytes in response to exposure to tumor cells may represent a mechanism whereby tumor cells subvert host immune defense against them.
Biochemical and Biophysical Research CommunicationsInhibition of adenylate cyclase by IL 2 in human T lymphocytes is mediated by protein kinase C
28 Citations1987Suzanne K. Beckner, William L. Farrar
The results suggest that the inhibition of adenylate cyclase in human T lymphocytes by IL 2 is mediated by protein kinase C.
Cellular ImmunologyFunctional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors
27 Citations1988Laurie B. Owen‐Schaub, William G. Loudon +2 more
The development of lytic function, Tac upregulation, and cellular proliferation was prohibited by trypsin, a treatment shown also to eliminate 125I-IL-2 binding to Tac-negative lymphocytes, suggesting the existence of such an alternate IL-2 receptor.
The Journal of ImmunologyRegulation of human natural killing. III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents.
26 Citations1984K H Leung, H S Koren
It is demonstrated that human NK cells activated by IFN or poly I:C were partially resistant to suppression by PGE2, PGD 2, PGA2, PGI2, dibutyryl cAMP, isoproterenol, and theophylline.
International Journal of ImmunopharmacologyEffects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells
22 Citations1982Kam H. Leung, Enrico Mihich
Results indicate that prostaglandins have immunomodulating activity affecting the early phase of the development of the CMI response in culture; they also have the ability to inhibit the cytolytic effect of effector cells generated in vivo.
Cancer Immunology ImmunotherapyEffect of dietary polyunsaturated fat and 7,12-dimethylbenz(a)-anthracene on rat splenic natural killer cells and prostaglandin E synthesis
17 Citations1986K H Leung, MargotM. Ip
Results from these experiments suggest that the stimulation of DMBA-induced mammary tumorigenesis by polyunsaturated fat and by DMBA itself may possibly be mediated by a transient decrease in splenic NK cell activity.
JNCI Journal of the National Cancer Institute3-Methylcholanthrene: Transient Inhibition of the Lytic Step of Mouse Natural Killer Cells<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>
13 Citations1983Terje Kalland, J.-G. Forsberg
The results are compatible with a significant role for NK cells during MCA carcinogenesis and indicate that a possible part of the tumorigenic effect of MCA is its early suppressive effect on NK cell activity.
International Journal of CancerInterleukin‐2 activated human killer lymphocytes: Lack of involvement of interferon in the development of IL‐2‐activated killer lymphocytes
12 Citations1987Nitin K. Damle, Laura V. Doyle
Neither endogenously generated nor exogenously added IFN had any effect on the IAK system, in contrast to their augmenting effects on NK cells and CTL.